Similar articles

• Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: implications for screening and prevention.

  Castellsagué X, Díaz M, de Sanjosé S, Muñoz N, Herrero R, Franceschi S, Peeling RW, Ashley R, Smith JS, Snijders PJ, Meijer CJ, Bosch FX; International Agency for Research on Cancer Multicenter Cervical Cancer Study Group. Castellsagué X, et al. J Natl Cancer Inst. 2006 Mar 1;98(5):303-15. doi: 10.1093/jnci/djj067. J Natl Cancer Inst. 2006. PMID: 16507827
• Etiology and prevention of cervical adenocarcinomas.

  Hildesheim A, Berrington de González A. Hildesheim A, et al. J Natl Cancer Inst. 2006 Mar 1;98(5):292-3. doi: 10.1093/jnci/djj098. J Natl Cancer Inst. 2006. PMID: 16507820 No abstract available.
• [Adenocarcinoma of the uterine cervix--risk factors].

  Stefănescu BI. Stefănescu BI. Rev Med Chir Soc Med Nat Iasi. 2007 Jan-Mar;111(1):155-60. Rev Med Chir Soc Med Nat Iasi. 2007. PMID: 17595861 Review. Romanian.
• [A vaccine against papillomavirus infections and cancer].

  Lehtinen M, Apter D, Heikkilä R, Heino P, Idänpään-Heikkilä I, Rimpilä K, Malm C, Zilliacus R. Lehtinen M, et al. Duodecim. 2002;118(13):1397-404. Duodecim. 2002. PMID: 12239887 Review. Finnish. No abstract available.
• Oral contraceptives as risk factors for cervical adenocarcinomas and squamous cell carcinomas.

  Lacey JV Jr, Brinton LA, Abbas FM, Barnes WA, Gravitt PE, Greenberg MD, Greene SM, Hadjimichael OC, McGowan L, Mortel R, Schwartz PE, Silverberg SG, Hildesheim A. Lacey JV Jr, et al. Cancer Epidemiol Biomarkers Prev. 1999 Dec;8(12):1079-85. Cancer Epidemiol Biomarkers Prev. 1999. PMID: 10613340